299660 — Cellid Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual cashflow statement for Cellid Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-4,126	-13,071	-22,865	-11,611	-12,259
Depreciation
Amortisation
Non-Cash Items	-1,134	717	8,847	316	1,246
Unusual Items
Other Non-Cash Items
Changes in Working Capital	1,004	1,860	-799	1,516	-2,036
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-3,763	-8,206	-12,216	-7,115	-10,315
Capital Expenditures	-11,715	-3,112	-1,203	-11,284	-18,415
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	16,885	-7,032	15,205	10,532	3,349
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	5,170	-10,144	14,002	-752	-15,066
Financing Cash Flow Items	109	760	1,343	746	2,967
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	387	20,085	1,263	12,993	21,025
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,794	1,735	3,049	5,126	-4,356